BlackRock Fund Advisors’s AstraZeneca AZN Stock Holding History

BlackRock Fund Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-3,477	Closed	-$248K	–	3771
2014 Q3	$248K	Sell	3,477 -248	-7%	-$18.2K	﹤0.01%	3401
2014 Q2	$277K	Sell	3,725 -112,360	-97%	-$8.12M	﹤0.01%	3372
2014 Q1	$7.53M	Buy	116,085 +21,500	+23%	+$1.39M	﹤0.01%	2564
2013 Q4	$5.62M	Buy	94,585 +7,500	+9%	+$407K	﹤0.01%	2751
2013 Q3	$4.52M	Buy	87,085 +20,128	+30%	+$1.01M	﹤0.01%	2880
2013 Q2	$3.17M	Buy	+66,957	New	+$3.41M	﹤0.01%	2960

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BlackRock Fund Advisors's AZN Position: Q4 2014 in Review

BlackRock Fund Advisors sold out of AstraZeneca (AZN) in Q4 2014, closing a stake of 3,477 shares — an estimated $248K sold.

BlackRock Fund Advisors first reported a position in AZN in Q2 2013 and held it in 6 quarters. The position peaked at $7.53M in Q1 2014. 404 funds tracked by Wall St. Rank hold AZN as of Q4 2014.

BlackRock Fund Advisors reported no remaining AstraZeneca position as of Q4 2014 after selling out during the quarter.
BlackRock Fund Advisors sold 3,477 AstraZeneca shares in Q4 2014, an estimated $248K.
BlackRock Fund Advisors first reported a position in AstraZeneca in Q2 2013 and held it in 6 quarters.
BlackRock Fund Advisors's AstraZeneca position peaked at $7.53M in Q1 2014.
404 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2014.

Based on BlackRock Fund Advisors's 13F filing for Q4 2014, filed 9 Feb 2015.